The global fluorescence in situ hybridization imaging systems market size is expected to reach USD 2.14 billion by 2030, expanding at a CAGR of 8.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing R&D investments pertaining to in vitro diagnostics are expected to drive the Fluorescence In Situ Hybridization (FISH) imaging systems market. The presence of government organizations, such as the European Diagnostic Manufacturers Association that focuses on the development and growth of the in vitro diagnostics market in Europe, is also contributing to growth.

Furthermore, FISH imaging systems are gaining popularity in diagnostics for the determination of suspected diseases caused by pathogens or bacteria. Increasing incidence of genetic diseases, such as lymphoma, solid tumors, leukemia, autism, and other developmental syndromes, is also expected to boost adoption. Growing penetration of fluoroscopy, microscopes, illuminators, and CCD cameras in testing for infectious diseases is expanding growth opportunities for these systems. Increasing prevalence of diseases with chromosomal aberrations, such as cancer and genetic abnormalities, as well as unmet diagnostic & clinical needs in developing countries, is anticipated to drive the market.

Gather more insights about the market drivers, restrains and growth of the Fluorescence In Situ Hybridization Imaging Systems Market

Moreover, increasing demand for rapid, sensitive, & accurate diagnostic techniques for validation of diseases, coupled with rising awareness, increase in healthcare expenditure, and extensive R&D for the development of novel imaging systems are also expected to drive growth over the forecast period.

Fluorescence In Situ Hybridization Imaging Systems Market Report Highlights

• Instruments held the largest market, whereas FISH imaging services are expected to grow at the fastest rate during the forecast period
• At present, the market penetration of FISH imaging in cancer diagnostics is very high, hence the diagnostic laboratories segment accounted for larger revenues
• Cancer diagnosis held the largest revenue share owing to increasing incidence of cancer, thus fueling the adoption of FISH imaging systems
• Among end-use segments, companion diagnostics is expected to witness faster growth than research and diagnostic segments
• Diagnostic laboratories held the dominant position in 2016 as these systems are predominantly used in various clinical studies for visualization of precancerous lesions in cervical cancer, assessing the risk of human papillomavirus, and for detection of leukemia, myelodysplastic syndrome, multiple myeloma, & chromosomal abnormalities
• North America held the largest revenue share owing to extensive adoption of these solutions in research and development across this region
• Asia Pacific is anticipated to exhibit lucrative CAGR over the forecast period due to the increase in investments by manufacturers & governments, supportive government initiatives in the biotechnology sector, and the presence of a large number of untapped opportunities
• The industry is highly competitive with a limited number of players holding a majority of the overall revenues. Some of the most notable market participants are Euroclone SpA, TissueGnostics GmbH, Agilent Technologies, Inc., Abnova Taiwan Corp, BioGenex Laboratories Inc., o Bio-View Ltd and General Electric Company. They account for a considerable share of the industry 

Browse more reports published by Grand View Research.

• Artificial Insemination Market Size, Share & Trends Analysis Report By Type (Intrauterine, Intracervical, Intravaginal, Intratubal), By Source Outlook, By End Use (AIH-Husband And AID-Donor), By Region, And Segment Forecasts, 2024 - 2030
• Intrapartum Monitoring Devices Market Size, Share & Trends Analysis Report By Product (Monitors, Electrodes), By End Use (Hospitals, Maternity Centers), By Region, And Segment Forecasts, 2024 - 2030 

List of Key Players in Fluorescence In Situ Hybridization Imaging Systems Market

• Euroclone SpA
• TissueGnostics GmbH
• Agilent Technologies, Inc.
• Abnova Taiwan Corp
• BioGenex Laboratories Inc
• Leica Biosystems Nussloch GmbH
• Bio-View Ltd
• Thermo Fisher Scientific Inc
• MetaSystems Probes GmbH 

About Grand View Research

Grand View Research is a full-time market research and consulting company registered in San Francisco, California. The company fully offers market reports, both customized and syndicates, based on intense data analysis. It also offers consulting services to business communities and academic institutions and helps them understand the global and business scenario to a significant extent. The company operates across multitude of domains such as Chemicals, Materials, Food and Beverages, Consumer Goods, Healthcare, and Information Technology to offer consulting services.

Explore Horizon, the world's most expansive market research database